The most dominant mutations in HPV–HNSCC affect cell cycle control and involve inactivation of the p53 and Rb-p16INK4A–cyclin D1 pathways (14, 15). The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.